News Site - Investor Navigation Corporate Profile Press Releases Events & Presentations Stock Information Stock Quote & Chart Historic Price Lookup Analyst Coverage Financial Filings SEC Filings Governance Documents & Charters Committee Composition Resources Investor FAQs Investor Email Alerts News Category - Any -Ikena OncologyImageneBio Year None2026202520242023202220212020 May 27, 2026 ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York PDF Version May 07, 2026 ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update PDF Version Apr 13, 2026 ImageneBio Announces $30 Million Private Placement PDF Version Mar 17, 2026 ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version Mar 10, 2026 ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update PDF Version Feb 26, 2026 ImageneBio to Participate in Leerink Global Healthcare Conference PDF Version Feb 10, 2026 ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer PDF Version
News Category - Any -Ikena OncologyImageneBio Year None2026202520242023202220212020 May 27, 2026 ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York PDF Version May 07, 2026 ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update PDF Version Apr 13, 2026 ImageneBio Announces $30 Million Private Placement PDF Version Mar 17, 2026 ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version Mar 10, 2026 ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update PDF Version Feb 26, 2026 ImageneBio to Participate in Leerink Global Healthcare Conference PDF Version Feb 10, 2026 ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer PDF Version
May 27, 2026 ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York PDF Version
May 07, 2026 ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update PDF Version
Mar 10, 2026 ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update PDF Version
Feb 10, 2026 ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer PDF Version
